Skip to content

Physical Activity in the Medical Workplace

Physical Activity in the Medical Workplace- a Way to Improve Physical and Mental Well-being?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02794727
Acronym
OPA
Enrollment
135
Registered
2016-06-09
Start date
2016-06-30
Completion date
2019-04-30
Last updated
2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity

Brief summary

Decreased physical activity is not only associated with multiple chronic medical conditions, including obesity, but also with depressed mood, and other negative emotions. As many employed adults spend a great deal of time at work where we are predominantly sedentary, strategies to increase physical activity at work are being pursued to help improve the physical and mental health of Americans. This 17 week randomized controlled trial will investigate changes of occupational physical activity in three groups: those provided with a FitBit® but not able to monitor their activity level, and those provided with activity goals and individual physical activity challenges, and those who do not use a FitBit®.

Detailed description

All subjects will be entered into a 4 week run-in phase where subjects will wear a blinded Fitbit during work hours. The baseline work activity is collected at this time. This phase is followed by a randomization to one of 3 groups: the blinded Fitbit group, the unblinded Fitbit group, and the group which will not wear any activity monitors. During these 12 weeks we will collect data on activity levels during work hours. Everyone will have a final contact at week 17 to close out the study.

Interventions

Subjects will wear a blinded Fitbit to monitor activity while in the workplace for 12 weeks.

DEVICEUnblinded Fitbit

Subjects will be unblinded to the Fitbit display for 12 weeks with set activity goals.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Be between 18 - 65 years of age * Be a Mayo Clinic employee at 0.75 FTE or more * Have no previous use of any activity monitor for 14 consecutive days or more * Not be pregnant by subject self report * Have a stable weight - defined as self-reported weight that has not changed more than 10% in the past 3 months * Not have any previous history of joint problems that limit free movement, as determined by the PI * Be able to participate fully in all aspects of the study * Have understood and signed study informed consent.

Exclusion criteria

* Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence or skew data collection - such as a position where they predominantly provide transport as part of their job.

Design outcomes

Primary

MeasureTime frameDescription
Change in Fitbit Step Count Per DayBaseline through Week 16change in number of daily steps as measured by the fitbit monitor

Countries

United States

Participant flow

Participants by arm

ArmCount
Blinded Fitbit
Subjects will wear the physical activity monitor (fitbit) for 12 weeks but will be blinded to the monitor display. Blinded Fitbit: Subjects will wear a blinded Fitbit to monitor activity while in the workplace for 12 weeks.
44
Unblinded Fitbit
Subjects will wear the physical activity monitor (fitbit) for 12 weeks. They will have access to the monitor display and will have consults with study physician to set goals for the duration of the study. Unblinded Fitbit: Subjects will be unblinded to the Fitbit display for 12 weeks with set activity goals.
46
No Fitbit
Subjects will not wear any activity monitor for 12 weeks.
45
Total135

Baseline characteristics

CharacteristicBlinded FitbitUnblinded FitbitNo FitbitTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants46 Participants45 Participants135 Participants
Age, Continuous41.8 years
STANDARD_DEVIATION 10.3
40.4 years
STANDARD_DEVIATION 9.7
45.5 years
STANDARD_DEVIATION 9.8
42.6 years
STANDARD_DEVIATION 10.1
Race/Ethnicity, Customized
other
6 Participants4 Participants2 Participants12 Participants
Race/Ethnicity, Customized
white, non-hispanic
38 Participants42 Participants43 Participants123 Participants
Sex: Female, Male
Female
37 Participants38 Participants39 Participants114 Participants
Sex: Female, Male
Male
7 Participants8 Participants6 Participants21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 460 / 45
other
Total, other adverse events
6 / 444 / 463 / 45
serious
Total, serious adverse events
0 / 440 / 461 / 45

Outcome results

Primary

Change in Fitbit Step Count Per Day

change in number of daily steps as measured by the fitbit monitor

Time frame: Baseline through Week 16

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Blinded FitbitChange in Fitbit Step Count Per Day-323.5 stepsStandard Error 90.5
Unblinded FitbitChange in Fitbit Step Count Per Day321.2 stepsStandard Error 88.4

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026